U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Vaccines, Blood & Biologics
  3. BALFAXAR
  1. Vaccines, Blood & Biologics

STN: 125776
Proper Name: Prothrombin complex concentrate, human-lans
Tradename: BALFAXAR
Manufacturer: Octapharma Pharmazeutika Produktiosges.m.b.H.
Indication:

  • For the urgent reversal of acquired coagulation factor deficiency induced by Vitamin K antagonist (VKA, e.g., warfarin) therapy in adult patients with need for an urgent surgery/invasive procedure.

Product Information

  • Package Insert - BALFAXAR
  • Demographic Subgroup Information – Prothrombin complex concentrate, human-lans
    Refer to Section 1.1 of the Clinical Review Memo for information about participation in the clinical trials and any analysis of demographic subgroup outcomes that is notable.

Supporting Documents

 

Back to Top